Journal Information
Vol. 6. Issue 1.
Pages 71 (January - February 2010)
Vol. 6. Issue 1.
Pages 71 (January - February 2010)
Full text access
Ageusia associated to treatment with pregabalin
Ageusia asociada a tratamiento con pregabalina
Visits
5405
Victor González Vallés, Javier Calvo Catalá
, Cristina Campos Fernández, Amalia Rueda Cid
Corresponding author
Unidad de Reumatología y Metabolismo Óseo, Consorcio Hospital General Universitario, Valencia, Spain
This item has received
Article information
Full text is only aviable in PDF
References
[1.]
I.W. Tremon-Lukaats, C. Megeff, M.M. Backonja.
Anticonvulsionants for neuropathic pain syndromes: Mechanism of action and place in therapy.
Drugs, 60 (2000), pp. 1029-1052
[2.]
J. López-Trigo, J. Sancho.
Pregabalina: un nuevo tratamiento para el dolor neuropático.
Neurología, 21 (2006), pp. 96-103
[3.]
D.M. Tassone, E. Óbice, J. Guyer, D. Nuzum.
Pregabalin: A novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial onset seizures, and anxiety disorders.
Clin Ther, 29 (2007), pp. 26-48
[5.]
Lyrica®. Ficha técnica. Available at: www.emea.europa.eu/humandocs/PDFs/EPAR/lyrica(H-546-PI-es.pdf
Copyright © 2010. Sociedad Española de Reumatología and Colegio Mexicano de Reumatología